Swiss CJD rise raises alarm
BSE-related brain disease could
emerge in different form.
12 July 2002
HELEN PEARSON
 |
| Cows are thought to have
caused a rise in variant, not sporadic CJD. |
| © alamy |
|
|
The number of people dying from sporadic Creutzfeldt-Jakob
disease (CJD) has risen sharply in Switzerland. The finding is
raising fears that 'mad cow disease' could have spread to humans
in another form1.
In Britain, a cattle epidemic of BSE is thought to have
triggered a brain disease called variant CJD in some people who
ate infected meat products. Variant CJD strikes young people.
Four years after Britain's BSE outbreak, Swiss cattle were
also hit by a BSE epidemic, which peaked in 1996. Now Swiss
epidemiologists have recorded an alarming rise in apparent cases
of sporadic CJD, a different form of the disease that affects
those over 60.
Each year between 1997 and 2000, 8 to 11 of Switzerland's 6.5
million people developed CJD. In 2001, 19 cases were reported; 7
were reported in the first quarter of 2002. This is around four
times higher than the reported incidence anywhere else,
including Britain.
There are many possible reasons for the climb - including a
simple statistical variation or improved disease reporting. The
most alarming possibility is that BSE has passed into humans and
caused sporadic CJD. At present, it is impossible for scientists
to judge if this has occurred.
Blip or climb?
The hike may be a random statistical blip - in which case
next year's figures may fall. Fluctuations have occurred in the
UK sporadic CJD figures over the past few years. "I'm still
hoping the numbers will go down," says the researcher who led
the study, Adriano Aguzzi of the Institute of Neuropathology and
National Reference Center for Human Prion Diseases in Zurich.
|
Increased awareness of the disease may have
produced more diagnoses
|
Roy Anderson
Imperial College London |
|
|
Epidemiologist Roy Anderson of Imperial College of Science,
Technology and Medicine, London, says his "preferred option" is
a reporting bias: that an increased awareness of the disease
amongst doctors and the public has produced more diagnoses.
But Aguzzi thinks that over-reporting is unlikely. He points
out that other countries - Britain, Austria and Germany - who
spend as much on CJD surveillance have not reported similar
sharp increases.
The infectious prion protein that causes CJD could also have
been transmitted from one patient to another via surgical
instruments, blood transfusions or some other medical procedure.
"It's a distinct possibility," says Aguzzi. Whether this is so
would become clear through scrutiny of clinical records.
Worst-case scenario
If BSE is the cause of Swiss sporadic CJD - the worst-case
scenario - researchers have to work out how the cattle disease
can cause two different forms of the human disease: variant CJD
in Britain and elsewhere in Europe, and sporadic CJD in
Switzerland.
This could be explained if British and Swiss cattle harboured
different strains of the infectious prion protein - but
preliminary experiments suggest that they are the same.
Alternatively, Swiss CJD could have leapt to humans through
the injection of vaccines or medicines produced using serum made
from cows, suggests Cornelia van Duijn of the European
collaborative group on CJD incidence at the Erasmus University
Medical School in Rotterdam, The Netherlands. Finding the source
of the disease has "got to be priority number one for Europe",
she says.
Researchers now hope to establish whether sporadic CJD came
from BSE. They will use 'strain typing': infecting mice with the
prions causing the two diseases and seeing if the symptoms match
up. "It's the best way to establish or exclude any suspected
link," says Moira Bruce of the Institute for Animal Health
Neuropathogenesis Unit in Edinburgh, UK. These experiments will
take at least a year. |